NurOwn® (MSC-NTF cells)
BCT-002-US
Phase 3 mab completed
Quick answer
NurOwn® (MSC-NTF cells) for Amyotrophic Lateral Sclerosis (ALS) is a Phase 3 program (mab) at BRAINSTORM CELL THERAPEUTICS INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BRAINSTORM CELL THERAPEUTICS INC.
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Phase
- Phase 3
- Modality
- mab
- Status
- completed